← Eichor
Study identifier: NCT07033039 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effects of Red and Infrared Photobiomodulation in Rhinoplasty at a Single Centre

Condition: Rhinoplasty · Edema  ·  Sponsor: University of Nove de Julho

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersYes

About this study

This single-centre, randomized, double-blind, sham-controlled clinical trial evaluates whether preoperative photobiomodulation (PBM) with red and infrared light can reduce early postoperative periorbital edema in patients undergoing primary open rhinoplasty with osteotomies. Sixty participants will be randomly assigned to receive active PBM or sham PBM one hour before surgery. The primary outcome is periorbital edema on postoperative day 3 measured using a validated ordinal clinical scale with standardized photographic documentation. Secondary outcomes include ecchymosis, postoperative pain, analgesic consumption, nasal tip skin thickness, and patient-reported functional and aesthetic outcomes. Participants will be followed for up to 12 months after surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Cinthya CG Duran, PhD  ·  5511981628831  ·  cinthya.cgduran@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital Paulista de OtorrinolaringologiaSão Paulo, São Paulo, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07033039